Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04180566 · ClinicalTrials.gov registry record · NA

Weekly Antepartum Testing in Women With BMI 30-40 and Neonatal Outcomes

A NA study, sponsored by Columbia University.

Terminated
Registry status
NA
Development phase
6
Enrollment target

NCT04180566: Clinical Trial NA study, sponsored by Columbia University.

NCT04180566 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04180566, a NA study, was terminated before completion, sponsored by Columbia University.

TERMINATED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

The purpose of study is to evaluate whether weekly antenatal testing in pregnant women with body mass index (BMI) 30-40 in the third trimester is associated with earlier delivery when compared to growth ultrasounds every 4 weeks. The investigators will also assess the differences in maternal and neonatal outcomes between the groups.

Primary Outcome

This is to measure the number of weeks that the baby has been in the uterus. It is measured from the first day of the woman's last menstrual cycle to the date of delivery. A normal pregnancy can range from 38 to 42 weeks. A significant delay in gestational age of delivery would be \> 7 days out of this range.

Interventions

  • OTHER Ultrasound Examination
  • OTHER Antenatal Testing (biophysical profile)

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2020-02-04
Est. Completion 2021-03-10
Phase NA
Columbia University

958 total trials

Why NCT04180566 stopped before completion

NCT04180566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Ultrasound Examination is the first listed.

NCT04180566 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04180566 about?

NCT04180566 is a clinical study titled "Weekly Antepartum Testing in Women With BMI 30-40 and Neonatal Outcomes". The purpose of study is to evaluate whether weekly antenatal testing in pregnant women with body mass index (BMI) 30-40 in the third trimester is associated with earlier delivery when compared to growth ultrasounds every 4 weeks. The investigators will also assess the differences in maternal and neo...

What is the current status of trial NCT04180566?

This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2020-02-04. Estimated completion is 2021-03-10.

What interventions are being tested in trial NCT04180566?

The interventions under investigation include: Ultrasound Examination (OTHER), Antenatal Testing (biophysical profile) (OTHER).

Who is sponsoring clinical trial NCT04180566?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04180566's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04180566, the US trial registry maintained by the National Library of Medicine. NCT04180566 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.